AZITHROMYCIN GRINDEKS õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

azithromycin grindeks õhukese polümeerikattega tablett

grindeks as - asitromütsiin - õhukese polümeerikattega tablett - 500mg 3tk

Cegfila (previously Pegfilgrastim Mundipharma) Euroopa Liit - eesti - EMA (European Medicines Agency)

cegfila (previously pegfilgrastim mundipharma)

mundipharma corporation (ireland) limited - pegfilgrastim - neutropeenia - immunostimulants, - neutropeenia ja febriilse neutropeenia esinemissageduse vähendamine ravitud tsütotoksilise kemoteraapia pahaloomulise kasvaja (välja arvatud krooniline müeloidne leukeemia ja müelodüsplastilised sündroomid).

Evenity Euroopa Liit - eesti - EMA (European Medicines Agency)

evenity

ucb pharma s.a. - romosozumab - osteoporoos - narkootikumid luuhaiguste raviks - evenity on näidustatud ravi raske osteoporoosi puhul postmenopausis naistel on suur risk luumurdude.

Bimzelx Euroopa Liit - eesti - EMA (European Medicines Agency)

bimzelx

ucb pharma s.a.   - bimekizumab - psoriaas - immunosupressandid - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.

SUNITINIB VIASANA kõvakapsel Eesti - eesti - Ravimiamet

sunitinib viasana kõvakapsel

viasana uab - sunitiniib - kõvakapsel - 25mg 30tk

SUNITINIB VIASANA kõvakapsel Eesti - eesti - Ravimiamet

sunitinib viasana kõvakapsel

viasana uab - sunitiniib - kõvakapsel - 50mg 30tk

SUNITINIB VIASANA kõvakapsel Eesti - eesti - Ravimiamet

sunitinib viasana kõvakapsel

viasana uab - sunitiniib - kõvakapsel - 12,5mg 30tk

VILDAGLIPTIN/METFORMIN SANOSWISS õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

vildagliptin/metformin sanoswiss õhukese polümeerikattega tablett

sanoswiss uab - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 30tk; 1000mg+50mg 120tk; 1000mg+50mg 56tk; 1000mg+50mg 180tk

VILDAGLIPTIN/METFORMIN SANOSWISS õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

vildagliptin/metformin sanoswiss õhukese polümeerikattega tablett

sanoswiss uab - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 60tk; 850mg+50mg 30tk; 850mg+50mg 10tk; 850mg+50mg 56tk; 850mg+50mg 120tk; 850mg+50mg 180tk

Aquipta Euroopa Liit - eesti - EMA (European Medicines Agency)

aquipta

abbvie deutschland gmbh & co. kg - atogepant - migreenihäired - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.